These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8975352

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapeutic approaches to healing esophagitis.
    Boyce HW.
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [Abstract] [Full Text] [Related]

  • 3. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ.
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG, Berstad A.
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Review article: the management of heartburn in pregnancy.
    Richter JE.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):749-57. PubMed ID: 16225482
    [Abstract] [Full Text] [Related]

  • 7. Update on drugs for gastro-oesophageal reflux disease.
    Keady S.
    Arch Dis Child Educ Pract Ed; 2007 Aug 01; 92(4):ep114-8. PubMed ID: 17644666
    [No Abstract] [Full Text] [Related]

  • 8. The treatment of gastroesophageal reflux disease.
    Kaplan B, Koppelo KL.
    W V Med J; 1994 Dec 01; 90(12):510-7. PubMed ID: 7863640
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC, Wolfe MM.
    Minerva Gastroenterol Dietol; 2004 Sep 01; 50(3):227-37. PubMed ID: 15729198
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K, Hashimoto T, Komazawa Y, Mihara T, Furuta K, Fujishiro H, Ishihara S, Amano Y, Hattori S, Kinoshita Y.
    Dig Liver Dis; 2005 Jul 01; 37(7):485-90. PubMed ID: 15975534
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN.
    Scand J Gastroenterol Suppl; 1989 Jul 01; 168():38-49. PubMed ID: 2575792
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Jul 01; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic procedures in gastroesophageal reflux disease].
    Tytgat GN.
    Z Gastroenterol; 1986 Sep 01; 24 Suppl 2():40-4. PubMed ID: 2877526
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.